One professor at a Midwestern university believes research should be focused elsewhere. Not all scientists are in agreement about the value of genetically modified plants. “But how much do you invest in that right now? Bayer has a lot invested in dicamba, so I think they’re going to bend over backward to make sure they have a label they can defend with the EPA, even if it’s just pre-plant use.”īayer officials were unable to provide comments as of press time. Some companies have plans for stacked traits to be ready by mid-decade. It’s going to be determined partly by lawsuits,” said Bryan Young, a weed scientist at Purdue University. The legal and regulatory system also play a role, including lawsuits regarding the use of Roundup and problems with dicamba damage to conventional crops. Many environmental groups are vocal about opposition to genetically modified plants. It’s not a concern to the scientific community.”Įxternal pressures are affecting GMO research. There is very low risk to human health and environmental health. ![]() “I don’t think there’s any doubt in the scientific community that the technology is very effective and has great potential. “It’s not an easy field to work in because you really have to do a lot of guessing and a lot of politics to determine where you direct your efforts,” said Ruth MacDonald, chair of the Food Science and Human Nutrition Department at Iowa State University. ![]() It is complicated by a variety of factors, including profitability, environmental opposition and public perception. Plant genetics is an area that presents multiple challenges to researchers, companies, farmers and consumers.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |